Hitachi Chemical Advanced Therapeutics Solutions has two decades of experience utilizing the PCT global service platform, which is solely focused on cell therapy CDMO services at cGMP standards—including clinical manufacturing, commercial manufacturing, and manufacturing development.
Please read the following article that details the precautions we are taking to keep our patients, clients, and employees safe during this time.
Read ArticleIn our "Meet Our Team Behind the Cells" series, we are featuring our talented and dedicated HCATS team! Our newest article features our Associate Compliance Investigator, Manilyn Joy Tupas. Read the article to learn more about her career journey and the opportunities she gained along the way.
Read Article
Hitachi Chemical Advanced Therapeutics Solutions has completed a new cell and gene therapy manufacturing facility in Allendale, NJ. The new facility is expected to create up to 500 new jobs and help expand HCATS’ distribution area and capacity alike.
Learn More & Download ImagesHCATS and Ori Biotech, an innovator in cell and gene therapy (CGT) manufacturing, have partnered to develop and commercialize technology solutions specific to the CGT industry.
Learn MorePlease read the following article that details the precautions we are taking to keep our patients, clients, and employees safe during this time.
Read ArticleIn our "Meet Our Team Behind the Cells" series, we are featuring our talented and dedicated HCATS team! Our newest article features our Associate Compliance Investigator, Manilyn Joy Tupas. Read the article to learn more about her career journey and the opportunities she gained along the way.
Read Article
Hitachi Chemical Advanced Therapeutics Solutions has completed a new cell and gene therapy manufacturing facility in Allendale, NJ. The new facility is expected to create up to 500 new jobs and help expand HCATS’ distribution area and capacity alike.
Learn More & Download ImagesHCATS and Ori Biotech, an innovator in cell and gene therapy (CGT) manufacturing, have partnered to develop and commercialize technology solutions specific to the CGT industry.
Learn MoreDue to COVID-19, we are taking all necessary precautions to keep our employees safe. Guidance from the government in both New Jersey and California has confirmed that due to the nature of our business, our sites are exempt from business closure mandates at this time. Our North American sites will remain open and our critical operations are not impacted.
